• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生物可吸收西罗莫司洗脱支架的重叠植入:一项光学相干断层扫描观察性研究。

Overlapping implantation of bioresorbable novolimus-eluting scaffolds: an observational optical coherence tomography study.

作者信息

Blachutzik Florian, Boeder Niklas, Wiebe Jens, Mattesini Alessio, Dörr Oliver, Most Astrid, Bauer Timm, Tröbs Monique, Röther Jens, Schlundt Christian, Achenbach Stephan, Hamm Christian, Nef Holger

机构信息

Friedrich-Alexander Universität Erlangen-Nürnberg (FAU), Department of Medicine 2-Cardiology, University Hospital Erlangen, Ulmenweg 18, 91054, Erlangen, Germany.

Justus Liebig Universität Giessen, University Hospital Giessen, Medical Clinic I, Giessen, Germany.

出版信息

Heart Vessels. 2017 Jul;32(7):781-789. doi: 10.1007/s00380-016-0932-9. Epub 2016 Dec 21.

DOI:10.1007/s00380-016-0932-9
PMID:28004176
Abstract

Overlapping implantation of bioresorbable vascular scaffolds is frequently necessary, but its influence on vessel and scaffold structure has not been thoroughly analyzed previously. The aim of this study was to analyze the acute effects of overlapping implantation on BRS as determined by optical coherence tomography (OCT). A total of 38 patients with de novo coronary artery stenoses who underwent OCT in the context of implantation of novolimus-eluting BRS (DESolve, Elixir Medical Corporation, Sunnyvale, California, USA) were investigated. In 15 patients, overlapping implantation of two BRS was performed, while 23 patients with implantation of one single BRS served as the control group. OCT data were retrospectively analyzed regarding acute scaffold implantation results. There were no significant differences between the overlap and control group in terms of residual in-scaffold area stenosis, scaffold area, mean or minimal lumen area, eccentricity index, incomplete scaffold apposition area or malapposition. While strut fracture was slightly more frequent in BRS with overlap its incidence was low overall. In patients with overlapping BRS, overlap segments did not display smaller lumen areas than segments without overlap (mean lumen area overlap: 8.16 ± 2.97 mm vs. no overlap: 7.70 ± 2.55 mm; p = 0.71; minimal lumen area overlap: 6.83 ± 2.71 mm vs. no overlap: 6.17 ± 2.58 mm; p = 0.37). Acute mechanical performance of novolimus-eluting BRS is not impaired by overlapping implantation. It can be assumed that vessel expansion compensates for the double scaffold layer in the overlap area resulting in a similar lumen area in overlap areas and in those with a single strut layer.

摘要

生物可吸收血管支架的重叠植入常常是必要的,但此前其对血管和支架结构的影响尚未得到充分分析。本研究的目的是通过光学相干断层扫描(OCT)分析重叠植入对生物可吸收血管支架的急性影响。共调查了38例在植入诺伐他汀洗脱生物可吸收血管支架(DESolve,Elixir Medical Corporation,美国加利福尼亚州桑尼维尔)时接受OCT检查的初发冠状动脉狭窄患者。15例患者进行了两个生物可吸收血管支架的重叠植入,而23例植入单个生物可吸收血管支架的患者作为对照组。对OCT数据进行回顾性分析以了解急性支架植入结果。重叠组和对照组在支架内残余面积狭窄、支架面积、平均或最小管腔面积、偏心指数、支架贴壁不全面积或贴壁不良方面无显著差异。虽然重叠的生物可吸收血管支架中支柱骨折略为常见,但其总体发生率较低。在重叠生物可吸收血管支架的患者中,重叠节段的管腔面积并不小于无重叠节段(平均管腔面积重叠:8.16±2.97mm vs无重叠:7.70±2.55mm;p = 0.71;最小管腔面积重叠:6.83±2.71mm vs无重叠:6.17±2.58mm;p = 0.37)。诺伐他汀洗脱生物可吸收血管支架的急性机械性能不会因重叠植入而受损。可以推测,血管扩张可补偿重叠区域的双层支架,从而使重叠区域和单支柱层区域的管腔面积相似。

相似文献

1
Overlapping implantation of bioresorbable novolimus-eluting scaffolds: an observational optical coherence tomography study.生物可吸收西罗莫司洗脱支架的重叠植入:一项光学相干断层扫描观察性研究。
Heart Vessels. 2017 Jul;32(7):781-789. doi: 10.1007/s00380-016-0932-9. Epub 2016 Dec 21.
2
Impact of strut thickness on acute mechanical performance: A comparison study using optical coherence tomography between DESolve 150 and DESolve 100.支架厚度对急性机械性能的影响:DESolve 150 和 DESolve 100 的光学相干断层扫描对比研究。
Int J Cardiol. 2017 Nov 1;246:74-79. doi: 10.1016/j.ijcard.2017.05.087. Epub 2017 May 24.
3
Post-dilatation after implantation of bioresorbable everolimus- and novolimus-eluting scaffolds: an observational optical coherence tomography study of acute mechanical effects.生物可吸收依维莫司和诺伐莫司洗脱支架植入后的后扩张:急性机械效应的光学相干断层扫描观察性研究
Clin Res Cardiol. 2017 Apr;106(4):271-279. doi: 10.1007/s00392-016-1048-z. Epub 2016 Oct 18.
4
Effect of Plaque Composition, Morphology, and Burden on DESolve Novolimus-Eluting Bioresorbable Vascular Scaffold Expansion and Eccentricity - An Optical Coherence Tomography Analysis.斑块成分、形态和负荷对DESolve诺伐他汀洗脱生物可吸收血管支架扩张及偏心度的影响——光学相干断层扫描分析
Cardiovasc Revasc Med. 2019 Jun;20(6):480-484. doi: 10.1016/j.carrev.2018.07.030. Epub 2018 Aug 2.
5
A new novolimus-eluting bioresorbable scaffold for large coronary arteries: an OCT study of acute mechanical performance.一种用于大型冠状动脉的新型诺华莫司洗脱生物可吸收支架:急性机械性能的光学相干断层扫描研究
Int J Cardiol. 2016 Oct 1;220:706-10. doi: 10.1016/j.ijcard.2016.06.160. Epub 2016 Jun 26.
6
Comparison of acute expansion of bioresorbable vascular scaffolds versus metallic drug-eluting stents in different degrees of calcification: An Optical Coherence Tomography Study.不同钙化程度下生物可吸收血管支架与金属药物洗脱支架急性扩张情况的比较:一项光学相干断层扫描研究
Catheter Cardiovasc Interv. 2017 Apr;89(5):798-810. doi: 10.1002/ccd.26676. Epub 2016 Oct 7.
7
Serial Multimodality Imaging and 2-Year Clinical Outcomes of the Novel DESolve Novolimus-Eluting Bioresorbable Coronary Scaffold System for the Treatment of Single De Novo Coronary Lesions.新型 DESolve 雷帕霉素洗脱生物可吸收冠状动脉支架系统治疗单支原发冠状动脉病变的 2 年临床结局及系列多模态影像学研究
JACC Cardiovasc Interv. 2016 Mar 28;9(6):565-74. doi: 10.1016/j.jcin.2015.12.004.
8
Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes.第二代生物可吸收依维莫司药物洗脱血管支架治疗冠状动脉原发狭窄的临床和影像学 6 个月随访结果。
Circulation. 2010 Nov 30;122(22):2301-12. doi: 10.1161/CIRCULATIONAHA.110.970772. Epub 2010 Nov 15.
9
Impact of overlapping on 1-year clinical outcomes in patients undergoing everolimus-eluting bioresorbable scaffolds implantation in routine clinical practice: Insights from the European multicenter GHOST-EU registry.在常规临床实践中接受依维莫司洗脱生物可吸收支架植入的患者中,重叠对1年临床结局的影响:来自欧洲多中心GHOST-EU注册研究的见解
Catheter Cardiovasc Interv. 2017 Apr;89(5):812-818. doi: 10.1002/ccd.26674. Epub 2016 Aug 12.
10
Effect of non-compliant balloon postdilatation on magnesium-based bioresorbable vascular scaffolds.非顺应性球囊后扩张对镁基生物可吸收血管支架的影响。
Catheter Cardiovasc Interv. 2019 Feb 1;93(2):202-207. doi: 10.1002/ccd.27794. Epub 2018 Sep 9.

引用本文的文献

1
Long-term results of long segment coronary artery lesions overlapped with novolimus-eluting DESolve scaffold: Disappointment or futuristic?长节段冠状动脉病变重叠应用依维莫司洗脱 DESolve 支架的长期结果:失望还是未来可期?
Anatol J Cardiol. 2021 Dec;25(12):912-919. doi: 10.5152/AnatolJCardiol.2021.25.
2
The DESolve novolimus bioresorbable Scaffold: from bench to bedside.DESolve诺伐他汀可生物吸收支架:从实验台到临床应用
J Thorac Dis. 2017 Aug;9(Suppl 9):S950-S958. doi: 10.21037/jtd.2017.07.25.
3
BRS implantation in long lesions requiring device overlapping: myth or reality?

本文引用的文献

1
Impact of overlapping on 1-year clinical outcomes in patients undergoing everolimus-eluting bioresorbable scaffolds implantation in routine clinical practice: Insights from the European multicenter GHOST-EU registry.在常规临床实践中接受依维莫司洗脱生物可吸收支架植入的患者中,重叠对1年临床结局的影响:来自欧洲多中心GHOST-EU注册研究的见解
Catheter Cardiovasc Interv. 2017 Apr;89(5):812-818. doi: 10.1002/ccd.26674. Epub 2016 Aug 12.
2
Absorb vs. DESolve: an optical coherence tomography comparison of acute mechanical performances.吸收与溶解:急性机械性能的光学相干断层扫描比较。
EuroIntervention. 2016 Aug 5;12(5):e566-73. doi: 10.4244/EIJV12I5A96.
3
在需要器械重叠的长病变中植入生物可吸收支架:神话还是现实?
J Thorac Dis. 2017 Aug;9(Suppl 9):S914-S922. doi: 10.21037/jtd.2017.06.35.
Relation Between Bioresorbable Scaffold Sizing Using QCA-Dmax and Clinical Outcomes at 1 Year in 1,232 Patients From 3 Study Cohorts (ABSORB Cohort B, ABSORB EXTEND, and ABSORB II).
在 3 个研究队列(ABSORB Cohort B、ABSORB EXTEND 和 ABSORB II)的 1232 名患者中,使用 QCA-Dmax 进行生物可吸收支架大小与 1 年临床结局的关系。
JACC Cardiovasc Interv. 2015 Nov;8(13):1715-26. doi: 10.1016/j.jcin.2015.07.026.
4
Everolimus-eluting bioresorbable stent vs. durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction: results of the randomized ABSORB ST-segment elevation myocardial infarction-TROFI II trial.依维莫司洗脱生物可吸收支架与依维莫司洗脱耐用聚合物金属支架治疗ST段抬高型心肌梗死患者的比较:随机ABSORB ST段抬高型心肌梗死-TROFI II试验结果
Eur Heart J. 2016 Jan 14;37(3):229-40. doi: 10.1093/eurheartj/ehv500. Epub 2015 Sep 23.
5
A randomized trial evaluating everolimus-eluting Absorb bioresorbable scaffolds vs. everolimus-eluting metallic stents in patients with coronary artery disease: ABSORB Japan.在冠状动脉疾病患者中评估依维莫司洗脱 Absorb 生物可吸收支架与依维莫司洗脱金属支架的随机试验:ABSORB 日本。
Eur Heart J. 2015 Dec 14;36(47):3332-42. doi: 10.1093/eurheartj/ehv435. Epub 2015 Sep 1.
6
Bioresorbable vascular scaffold overlap evaluation with optical coherence tomography after implantation with or without enhanced stent visualization system (WOLFIE study): a two-centre prospective comparison.生物可吸收血管支架植入后使用或不使用增强型支架可视化系统的光学相干断层扫描重叠评估(WOLFIE研究):一项两中心前瞻性比较研究
Int J Cardiovasc Imaging. 2016 Feb;32(2):211-223. doi: 10.1007/s10554-015-0756-1. Epub 2015 Sep 1.
7
Incidence and Potential Mechanism(s) of Post-Procedural Rise of Cardiac Biomarker in Patients With Coronary Artery Narrowing After Implantation of an Everolimus-Eluting Bioresorbable Vascular Scaffold or Everolimus-Eluting Metallic Stent.生物可吸收雷帕霉素洗脱血管支架或雷帕霉素洗脱金属支架置入后冠状动脉狭窄患者术后心脏生物标志物升高的发生率及潜在机制。
JACC Cardiovasc Interv. 2015 Jul;8(8):1053-1063. doi: 10.1016/j.jcin.2015.06.001.
8
Neointimal coverage and late apposition of everolimus-eluting bioresorbable scaffolds implanted in the acute phase of myocardial infarction: OCT data from the PRAGUE-19 study.急性心肌梗死急性期植入依维莫司洗脱生物可吸收支架的新生内膜覆盖情况及晚期贴壁情况:来自PRAGUE-19研究的光学相干断层扫描数据
Heart Vessels. 2016 Jun;31(6):841-5. doi: 10.1007/s00380-015-0679-8. Epub 2015 Apr 21.
9
Appropriate use of bioresorbable vascular scaffolds in percutaneous coronary interventions: a recommendation from experienced users : A position statement on the use of bioresorbable vascular scaffolds in the Netherlands.经皮冠状动脉介入治疗中生物可吸收血管支架的合理应用:有经验用户的推荐意见:荷兰关于生物可吸收血管支架应用的立场声明。
Neth Heart J. 2015 Mar;23(3):161-5. doi: 10.1007/s12471-015-0651-3.
10
Contemporary practice and technical aspects in coronary intervention with bioresorbable scaffolds: a European perspective.当代经皮冠状动脉介入治疗中生物可吸收支架的应用及技术要点:欧洲视角。
EuroIntervention. 2015 May;11(1):45-52. doi: 10.4244/EIJY15M01_05.